Navigation Links
AEterna Zentaris Reports Third Quarter 2008 Financial and Operating Results
Date:11/13/2008

All amounts are in U.S. dollars

QUEBEC CITY, Nov. 13 /PRNewswire-FirstCall/ - AEterna Zentaris Inc. (NASDAQ: AEZS, TSX: AEZ), a global biopharmaceutical company focused on endocrinology and oncology, today reported financial and operating results for the third quarter ended September 30, 2008.

Third Quarter 2008 Highlights

- Appointment on September 1, 2008, of Juergen Engel, Ph.D. as President

and CEO of AEterna Zentaris, replacing Juergen Ernst who had been

acting as Interim President and CEO since April 2008. Mr. Ernst, the

former Chairman of the Company, was appointed Executive Chairman

effective September 1, 2008;

- Completion of patient recruitment for the second efficacy trial of the

Phase 3 program in benign prostatic hyperplasia (BPH) with lead

compound, cetrorelix;

- Start of second stage of recruitment for the Phase 2 trial in ovarian

cancer with AEZS-108. The trial is part of a Phase 2 program in

gynaecological cancers which will include up to 82 women;

- Signing of a license and cooperation agreement for the

commercialization of cetrorelix in BPH, with Handok Pharmaceuticals

Co., Ltd. (Handok) for the Korean market. Subsequent to quarter end,

signing of another agreement with Handok for the commercialization of

ozarelix in BPH for the Korean market; and

- Recovery of worldwide rights from Ardana plc (LSE: ARA) for the Growth

Hormone Secretagogue (GHS) compound, AEZS-130. Future development

options are currently being evaluated for the use of this compound in

growth hormone deficiencies.

Subsequent to Quarter-End

On November 11, 2008, AEterna Ze
'/>"/>

SOURCE AETERNA ZENTARIS INC.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related biology technology :

1. AEterna Zentaris to Announce Third Quarter 2008 Financial and Operating Results on November 13, 2008
2. AEterna Zentaris Agrees to Sell Cetrotide(R) Royalty Stream for $52.5 Million to Cowen Healthcare Royalty Partners
3. AEterna Zentaris Reaches 2nd Stage of Patient Recruitment for Phase 2 Trial in Endometrial Cancer with the Innovative LHRH Receptor Targeted Conjugate, AEZS-108
4. AEterna Zentaris to Present at Upcoming Oppenheimer 19th Annual Healthcare Conference
5. AEterna Zentaris Receives Notification from Nasdaq Relating to Minimum Bid Price
6. AEterna Zentaris Completes Patient Recruitment for Second Efficacy Trial of its Phase 3 Program with Cetrorelix in Benign Prostatic Hyperplasia
7. AEterna Zentaris to Present at BioContact Quebec on October 2, 2008
8. AEterna Zentaris to Present at Upcoming CIBC World Markets 7th Annual Eastern Investor Conference
9. AEterna Zentaris Reports Second Quarter 2008 Financial and Operating Results
10. AEterna Zentaris Announces Appointment of Prof. Jurgen Engel, Ph.D. as New President and CEO
11. AEterna Zentaris to Announce Second Quarter 2008 Financial and Operating Results on August 12, 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... Westlake Village, Calif. (PRWEB) January 15, 2014 ... cancer treatment and management through the genomic analysis of ... will offer Therapy Finder™, a web-based cancer decision support ... a reporting option with Cynvenio’s ClearID™ genomic test, Therapy ...
(Date:1/15/2014)... , January 15, 2014 A study has ... on the Formula 1 track could help to tackle the ... Technologies (MAT), Stowhealth (a GP surgery based in Stowmarket) and ... provider Simplyhealth. Telemetry technology, which is inspired by ...
(Date:1/15/2014)... 2014 DTS Language Services, Inc . ... Portal for Life Science organizations who need document translations. ... matter of their documents in advance with a selection of ... of translations, often a critical factor in clinical and scientific ...
(Date:1/15/2014)... TaiGen Biotechnology Company, Limited ("TaiGen") today announced that ... leading Russian pharmaceutical company, to develop and commercialize nemonoxacin ... , Turkey and other ... novel antibiotic for the treatment of bacterial infections including ...
Breaking Biology Technology:Cynvenio Offers New Breast Cancer Therapy Finder Application for its ClearID Breast Cancer Genomic Test 2Cynvenio Offers New Breast Cancer Therapy Finder Application for its ClearID Breast Cancer Genomic Test 3Formula 1 Technology Tackles Obesity in Unique Healthcare Partnership 2Formula 1 Technology Tackles Obesity in Unique Healthcare Partnership 3Formula 1 Technology Tackles Obesity in Unique Healthcare Partnership 4DTS Improves Efficiency for Life Science Document Translations 2TaiGen Biotechnology Signed Exclusive License Agreement with R-Pharm for Nemonoxacin (Taigexyn(R)) 2TaiGen Biotechnology Signed Exclusive License Agreement with R-Pharm for Nemonoxacin (Taigexyn(R)) 3TaiGen Biotechnology Signed Exclusive License Agreement with R-Pharm for Nemonoxacin (Taigexyn(R)) 4
... therapy promises to be one of the most important frontiers in medicine. ... seems to hold significant potential in terms of developing such approaches. By ... $484 million. , ... San Jose, CA (PRWEB) November 4, 2008 -- ...
... which way you look at it, the notion of harvesting ... is more absorbing than ever. , Researchers at Rensselaer Polytechnic ... two major hurdles facing solar energy. By developing a new ... solar panels and allows those panels to absorb the entire ...
... Mich., Nov. 3 Diplomat Specialty Pharmacy,today announced ... company,s executive,management team. Dr. Patel will serve as ... responsible for the management and development,of Diplomat,s Chicago ... to develop and implement specialty pharmacy programs. Dr.,Patel ...
Cached Biology Technology:World Gene Therapy Market to Reach $484 Million by 2015, According to New Report by Global Industry Analysts, Inc. 2World Gene Therapy Market to Reach $484 Million by 2015, According to New Report by Global Industry Analysts, Inc. 3Solar power game-changer: 'Near perfect' absorption of sunlight, from all angles 2Solar power game-changer: 'Near perfect' absorption of sunlight, from all angles 3Diplomat Specialty Pharmacy Hires Rinku A. Patel, PharmD as Director of Pharmacy Development and Operations 2
(Date:4/18/2014)... A team of researchers led by a University of ... receive a $7.5 million Department of Defense grant to ... scientific foundations for the predictable design of light-weight, tough ... of structures from plants and animals, including the mantis ... biological systems have constructed over millions of years and ...
(Date:4/17/2014)... drug under clinical trials to treat tuberculosis could be ... act against various bacteria, fungal infections and parasites, yet ... Illinois chemists and collaborators. , Led by U. of ... different ways the drug SQ109 attacks the tuberculosis bacterium, ... pathogens from yeast to malaria and how targeting ...
(Date:4/17/2014)... word for chili peppers. Information about archaeological remains of ... of the appearance of words for chili peppers in ... domesticated and highlight the value of multi-proxy data analysis. ... of nine papers presented in a special feature issue ... Sciences on plant and animal domestication edited by ...
Breaking Biology News(10 mins):Mantis shrimp, toucan and trilobite, oh my 2Mantis shrimp, toucan and trilobite, oh my 3Multitarget TB drug could treat other diseases, evade resistance 2Chickens to chili peppers 2Chickens to chili peppers 3
... identify potential genetic regulators in planarian stem cells, Whitehead ... the two main functions of stem cells. Three of ... proteins similar to those known to regulate mammalian embryonic ... more attractive model for studying stem cell biology in ...
... Ice Age bones indicate that humans in Ohio hunted or ... curator of archaeology at The Cleveland Museum of Natural History, ... 2012 online issue of the journal World Archaeology . ... 1998 in the collections of the Firelands Historical Society Museum ...
... dozen years, scientists have known that minuscule strings of genetic material ... finding out what they do hasn,t been easy. Now a scientist ... to turn off small RNAs and find out just how important ... just the half of it. What we are is also driven ...
Cached Biology News:Planarian genes that control stem cell biology identified 2Planarian genes that control stem cell biology identified 3Research reveals first evidence of hunting by prehistoric Ohioans 2Turning off small RNA 2
... corresponds to amino acids 2-105 from human ... successfully used in Western blot, immunocytochemistry and ... antibody detects an ~ 60 kDa protein ... been used in immunoprecipitation and immunocytochemical procedures. ...
... suit the widest possible range of sample ... Labware carriers can be placed at any ... for the user, thanks to a numbered ... guided into position. This allows easy removal ...
... was developed in the late 1960s by ... the earliest commercial pioneers of immunoassay in ... in 1987. Sac-Cel rapidly found favour with ... "in house" radioimmunoassays, and became a benchmark ...
... N,N- bis- (3-D-Gluconamidopropyl)deoxycholamide ... analog of CHAPS and CHAPSO. Has reduced ... anion exchange chromatography on DEAE-cellulose. Aggregation number: ... Soluble in H 2 O. Aggregation number ...
Biology Products: